• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

孕期对活化蛋白C耐药性的发展。

Development of resistance to activated protein C during pregnancy.

作者信息

Cumming A M, Tait R C, Fildes S, Yoong A, Keeney S, Hay C R

机构信息

University Department of Haematology, Manchester Royal Infirmary.

出版信息

Br J Haematol. 1995 Jul;90(3):725-7. doi: 10.1111/j.1365-2141.1995.tb05610.x.

DOI:10.1111/j.1365-2141.1995.tb05610.x
PMID:7647019
Abstract

We measured activated protein C (APC) anticoagulant activity in 20 healthy women at 14-20, 28 and 36 weeks gestation, and at 1 d post-partum. Significant reductions in the mean APC sensitivity ratio (APC-SR) were observed at all stages of pregnancy studied compared with the mean APC-SR obtained for baseline measurements carried out at > 8 weeks post-partum. APC resistance was seen in 8/19 (42%) and in 11/20 (55%) women at 14-20 and 28 weeks gestation respectively. The development of resistance to APC may contribute to the increased risk of thrombosis during pregnancy.

摘要

我们测量了20名健康女性在妊娠14 - 20周、28周和36周以及产后1天时的活化蛋白C(APC)抗凝活性。与产后8周以上进行的基线测量所获得的平均APC敏感性比值(APC-SR)相比,在研究的妊娠各阶段均观察到平均APC-SR显著降低。分别在妊娠14 - 20周和28周时,19名女性中有8名(42%)和20名女性中有11名(55%)出现了APC抵抗。对APC产生抵抗可能会增加孕期血栓形成的风险。

相似文献

1
Development of resistance to activated protein C during pregnancy.孕期对活化蛋白C耐药性的发展。
Br J Haematol. 1995 Jul;90(3):725-7. doi: 10.1111/j.1365-2141.1995.tb05610.x.
2
Changes of resistance to activated protein C in the course of pregnancy and prevalence of factor V mutation.
Aust N Z J Obstet Gynaecol. 1998 May;38(2):200-4. doi: 10.1111/j.1479-828x.1998.tb03002.x.
3
Haemostatic changes and acquired activated protein C resistance in normal pregnancy.正常妊娠中的止血变化与获得性活化蛋白C抵抗
Blood Coagul Fibrinolysis. 2007 Oct;18(7):685-8. doi: 10.1097/MBC.0b013e3282f09835.
4
Resistance to activated protein C due to mutated factor V as a novel cause of inherited thrombophilia.因因子V突变导致的活化蛋白C抵抗作为遗传性血栓形成倾向的新病因。
Haematologica. 1995 Jul-Aug;80(4):344-56.
5
Influence of factor VIII/von Willebrand complex on the activated protein C-resistance phenotype and on the risk for venous thromboembolism in heterozygous carriers of the factor V Leiden mutation.凝血因子VIII/血管性血友病因子复合物对凝血因子V莱顿突变杂合子携带者活化蛋白C抵抗表型及静脉血栓栓塞风险的影响。
Blood Coagul Fibrinolysis. 1999 Oct;10(7):409-16.
6
Resistance to activated protein C in unselected patients with arterial and venous thrombosis.
Am J Hematol. 1997 Jun;55(2):59-64. doi: 10.1002/(sici)1096-8652(199706)55:2<59::aid-ajh2>3.0.co;2-1.
7
Resistance to activated protein C is a risk factor for pregnancy-related venous thrombosis in the absence of the F5 rs6025 (factor V Leiden) polymorphism.对活化蛋白 C 的抵抗是妊娠相关静脉血栓形成的危险因素,而不存在 F5 rs6025(因子 V 莱顿)多态性。
Br J Haematol. 2011 Jul;154(2):241-7. doi: 10.1111/j.1365-2141.2011.08712.x. Epub 2011 May 12.
8
Inherited resistance to activated protein C caused by presence of the FV:Q506 allele as a basis of venous thrombosis.
Haemostasis. 1996 Oct;26 Suppl 4:301-14. doi: 10.1159/000217311.
9
Search for mutations in the genes for coagulation factors V and VIII with a possible predisposition to activated protein C resistance.
Eur J Clin Invest. 1997 Apr;27(4):340-5. doi: 10.1046/j.1365-2362.1997.1180660.x.
10
Enhanced anticoagulant response to activated protein C in patients with IDDM.胰岛素依赖型糖尿病患者对活化蛋白C的抗凝反应增强。
Diabetes. 1995 Sep;44(9):1033-7. doi: 10.2337/diab.44.9.1033.

引用本文的文献

1
Thrombolysis and thrombectomy in a first trimester stroke: expanding the evidence for acute ischemic stroke management in pregnancy. Illustrative case.孕早期卒中的溶栓和取栓治疗:拓展妊娠期急性缺血性卒中管理的证据。病例说明。
J Neurosurg Case Lessons. 2025 Oct 6;10(14). doi: 10.3171/CASE25126.
2
Analytical performance of the endogenous thrombin potential-based activated protein C resistance assay on the automated ST Genesia system.基于内源性凝血酶原时间的活化蛋白 C 抵抗检测在自动化 ST Genesia 系统上的分析性能。
Res Pract Thromb Haemost. 2022 Apr 7;6(3):e12684. doi: 10.1002/rth2.12684. eCollection 2022 Mar.
3
How can Secondary Thromboprophylaxis in High-Risk Pregnant Patients be Improved?
高危妊娠患者如何改善二级血栓预防?
Clin Appl Thromb Hemost. 2022 Jan-Dec;28:10760296211070004. doi: 10.1177/10760296211070004.
4
A case-control study on factor V Leiden: an independent, gender-dependent risk factor for venous thromboembolism.一项关于凝血因子V莱顿突变的病例对照研究:静脉血栓栓塞症的一个独立的、与性别相关的危险因素
Thromb J. 2021 Oct 19;19(1):74. doi: 10.1186/s12959-021-00328-0.
5
Factor V Leiden G1691A and Prothrombin Gene G20210A Mutations on Pregnancy Outcome.凝血因子V莱顿G1691A突变和凝血酶原基因G20210A突变对妊娠结局的影响。
Cureus. 2021 Aug 15;13(8):e17185. doi: 10.7759/cureus.17185. eCollection 2021 Aug.
6
Ischemic stroke and cerebral venous sinus thrombosis in pregnancy.妊娠相关的缺血性脑卒中及颅内静脉窦血栓形成。
Handb Clin Neurol. 2020;172:3-31. doi: 10.1016/B978-0-444-64240-0.00001-5.
7
The pattern and magnitude of "in vivo thrombin generation" differ in women with preeclampsia and in those with SGA fetuses without preeclampsia.子痫前期女性与无子痫前期的小于胎龄儿女性的“体内凝血酶生成”模式和程度有所不同。
J Matern Fetal Neonatal Med. 2018 Jul;31(13):1671-1680. doi: 10.1080/14767058.2017.1323327. Epub 2017 May 23.
8
Management of inherited thrombophilia in pregnancy.妊娠期遗传性血栓形成倾向的管理。
Womens Health (Lond). 2016 Jul;12(4):433-41. doi: 10.1177/1745505716653702.
9
Polymorphisms in factor V and antithrombin III gene in recurrent pregnancy loss: a case-control study in Indian population.复发性流产中凝血因子V和抗凝血酶III基因多态性:印度人群的病例对照研究
J Thromb Thrombolysis. 2015 May;39(4):481-8. doi: 10.1007/s11239-015-1186-6.
10
Coagulation and placenta-mediated complications.凝血及胎盘介导的并发症。
Rambam Maimonides Med J. 2014 Oct 29;5(4):e0034. doi: 10.5041/RMMJ.10168. eCollection 2014 Oct.